Tresiba to Lantus Conversion Calculator

Understanding Tresiba and Lantus

Both Tresiba (insulin degludec) and Lantus (insulin glargine U-100) are long-acting basal insulins used to manage blood glucose levels in people with type 1 and type 2 diabetes. They provide a steady release of insulin over an extended period, helping to keep blood sugar stable between meals and overnight.

Tresiba (Insulin Degludec)

• Duration of Action: Over 42 hours, allowing for flexible dosing times.
• Peakless Profile: Provides a very flat and consistent insulin release.
• Dosing Frequency: Typically once daily, but can be adjusted for flexibility.

Lantus (Insulin Glargine U-100)

• Duration of Action: Approximately 24 hours.
• Peakless Profile: Also designed to be peakless, though some individuals may experience a subtle peak.
• Dosing Frequency: Typically once daily, usually at the same time each day.

Why Convert from Tresiba to Lantus?

There are several reasons why a healthcare provider might recommend converting from Tresiba to Lantus (or vice-versa). These can include:

• Insurance Coverage: Changes in insurance plans might favor one insulin over the other.
• Cost: One insulin might be more affordable than the other.
• Patient Preference: Some individuals may prefer the dosing schedule or feel better on one insulin.
• Clinical Response: A patient's blood glucose control might be better optimized with a different insulin profile.
• Availability: Supply chain issues or local pharmacy stock.

Regardless of the reason, any conversion should always be done under the strict guidance of a qualified healthcare professional.

The Tresiba to Lantus Conversion Ratio: Is it 1:1?

For many patients, the conversion from Tresiba to Lantus is often considered to be a 1:1 unit-to-unit conversion as a starting point. This means if you are taking 20 units of Tresiba per day, your initial Lantus dose might be recommended as 20 units per day.

However, it's crucial to understand that this is a general guideline. Differences in the pharmacokinetic and pharmacodynamic profiles of these insulins, particularly Tresiba's longer duration of action (over 42 hours vs. Lantus's ~24 hours), mean that a direct 1:1 conversion might not always be the final dose. Some healthcare providers may recommend starting with a slightly lower Lantus dose (e.g., 80-90% of the Tresiba dose) to mitigate the risk of hypoglycemia and then titrate up as needed.

Key Considerations During Conversion

Converting basal insulins requires careful monitoring and adjustment. Here are critical factors your healthcare team will consider:

1. Half-Life and Duration of Action

Tresiba has a significantly longer half-life than Lantus. When switching from Tresiba to Lantus, the body will still have Tresiba in its system for a day or two, which can influence initial Lantus dosing.

2. Risk of Hypoglycemia

Due to the differences in insulin profiles and the potential for overlapping insulin activity during the transition, there is an increased risk of low blood sugar (hypoglycemia). Close monitoring of blood glucose is paramount.

3. Blood Glucose Monitoring

Frequent blood glucose monitoring, especially during the first few days and weeks after conversion, is essential. This helps the healthcare provider assess the effectiveness of the new dose and make necessary adjustments.

4. Titration Process

Your doctor will likely start you on an estimated Lantus dose and then guide you through a titration process. This involves gradually adjusting the dose based on your blood glucose readings (fasting and pre-meal) to find the optimal dose that achieves target glucose levels without causing hypoglycemia.

5. Individual Variability

Every individual responds differently to insulin. Factors like diet, exercise, stress, and other medications can all affect insulin requirements. What works for one person may not work for another.

6. Dosing Schedule

While both are typically once-daily, Lantus is usually taken at the same time each day due to its 24-hour action profile. Tresiba offers more flexibility due to its ultra-long duration.

How to Use This Calculator

Our Tresiba to Lantus Conversion Calculator is designed to provide a quick estimate based on a common 1:1 conversion ratio:

1. Enter your current daily Tresiba dose (in units) into the designated field.
2. Click the "Calculate Lantus Dose" button.
3. The estimated Lantus daily dose will be displayed.

Remember, this is an informational tool. The precise dose for you must be determined by your doctor.

Important Medical Disclaimer

The information provided on this page, including the calculator, is for educational and informational purposes only, and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Conclusion

Converting from Tresiba to Lantus is a common adjustment in diabetes management, often initiated due to various practical or clinical considerations. While a 1:1 conversion is a frequently used starting point, the process requires careful medical supervision, close blood glucose monitoring, and a personalized titration plan to ensure safety and optimal glycemic control. Always engage with your healthcare team to navigate such transitions successfully.